Regeneron Pharmaceuticals Inc. — Sponsor Intelligence | 74 EU Trials

Filter these 74 trials by condition, phase, country and more.

Open in Search →

74 Registered trials

25 Recruiting

33 Completed trials

18 Countries active

73 Unique IMPs

100% Results reported

Phase III

Phase II

Phase I

Phase I (FiH)

Phase III: 23 Phase II/III: 2 Phase II: 17 Phase I/II: 1 Phase IV: 1 Phase I: 16 Phase I (Other): 4 Phase I (FiH): 10

Oversight events:

1 serious breach 3 temporary halts 2 corrective measures across 4 trials

View oversight register →

100%

33 of 33 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Non-small cell lung cancer 7 Malignant melanoma 3 Diffuse large B-cell lymphoma 3 Non-Hodgkin's lymphoma unspecified histology aggressive recurrent 2 Follicle centre lymphoma follicular grade I II III 2 Peritoneal cancer index 2 Hereditary angioedema 2 Ovarian cancer recurrent 2 Fallopian tube cancer 2 Eosinophilic gastritis 1 Follicular lymphoma 1 Iron overload 1

Top IMPs

CEMIPLIMAB 16 LINVOSELTAMAB 7 DEXAMETHASONE 5 DIPHENHYDRAMINE HYDROCHLORIDE 5 FIANLIMAB 5 ODRONEXTAMAB 5 PARACETAMOL 5 REGN7508 5 CARBOPLATIN 4 CEMDISIRAN 4 CISPLATIN 4 DEXAMETHASONE SODIUM PHOSPHATE 4

All trials

74 total

A Study to Learn about the Long-Term Health of Adult Participants from a Previous Study of a New Melanoma Treatment Pending

2024-517729-20-00 Phase II 1 country CEMIPLIMAB; FIANLIMAB
A Study Evaluating Mibavademab Treatment of Obesity due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults Pending

2024-518674-14-00 Phase III 1 country MIBAVADEMAB
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis. Pending

2024-519298-21-00 Phase III 8 countries REGN7508
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants with Solid and Hematologic Cancers Pending

2024-519299-16-00 Phase III 2 countries APIXABAN; REGN7508
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy with Standard-of-Care Combination Regimens … Pending

2024-519504-27-00 Phase III 10 countries ACICLOVIR; BORTEZOMIB; CARFILZOMIB; DARATUMUMAB; DEXAMETHASONE PHOSPHATE; DIPHEN…
A Study to Evaluate how Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) wh… Pending

2024-519709-37-00 Phase III 3 countries CEMDISIRAN; POZELIMAB
REGN7508 versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis after Total Knee Arthroplasty in Adult Participants Pending

2025-520479-25-00 Phase III 2 countries REGN7508
A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants Pending

2025-521713-57-00 Phase I (FiH) 1 country REGN7041
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants Pending

2025-521758-40-00 Phase I 1 country
A Trial to Study if REGN17372 in Combination with Linvoseltamab is Tolerable for Adult Participants with Relapsed/Refractory Multiple Myelom… Pending

2025-522776-93-00 Phase I 1 country DEXAMETHASONE; DIPHENHYDRAMINE HYDROCHLORIDE; LINVOSELTAMAB; PARACETAMOL; REGN17…
A First-In-Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination with Cemiplimab Works in Adult Participan… Pending

2025-523399-22-00 Phase I (FiH) 4 countries CEMIPLIMAB; IGG4 ANTIBODY FRAGMENT AGAINST PROGRAMMED CELL DEATH PROTEIN 1 FUSED…
A First in Human Study to Assess Safety, Tolerability and Pharmacokinetics of a single dose of REGN22044 in Healthy Adults Pending

2025-523562-24-00 Phase I 1 country
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants with Atopic Dermatitis Pending

2025-524205-32-00 Phase I 1 country
Safety and Tolerability of REGN17235 in Adult Participants with Clonal Cytopenia of Undetermined Significance and Low-Risk Myelodysplastic S… Pending

2026-525464-18-00 Phase I 1 country
Study of 3 Monoclonal Antibodies (REGN9933, REGN7508, and REGN9533) in Adult Participants with End-Stage Kidney Disease on Hemodialysis Pending

2026-525844-14-00 Phase I (Other) 1 country
Phase 2 Study of REGN13335 in Adult Participants with Pulmonary Arterial Hypertension (PAH) Recruiting

2024-514754-79-00 Phase II 7 countries HUMAN IGG4 KAPPA MONOCLONAL ANTIBODY AGAINST PLATELET-DERIVED GROWTH FACTOR SUBU…
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab a… Recruiting

2023-505172-29-00 Phase II 5 countries CEMIPLIMAB; CEMIPLIMAB, FIANLIMAB
A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better than Anti-PD1 Alone in Adult Participants with Resectable Stage 3 or 4… Recruiting

2022-502825-17-00 Phase II 8 countries CEMIPLIMAB; CEMIPLIMAB, FIANLIMAB; FIANLIMAB
A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced … Recruiting

2023-503221-19-00 Phase II 3 countries CEMIPLIMAB; ENOMIMERAN, RBL005.3, RBL007.2, RBL012.2, RBL027.2, RBL035.2
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants with Eosinophilic Gastritis with or without Eosinophilic Duod… Recruiting

2022-500795-62-00 Phase II 3 countries DUPILUMAB
A trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressi… Recruiting

2022-502783-21-00 Phase III 10 countries ODRONEXTAMAB
A trial to learn if odronextamab is safe and well-tolerated and how well it works compared to rituximab combined with different types of che… Recruiting

2022-502660-20-00 Phase III 8 countries ODRONEXTAMAB; RITUXIMAB
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given with Either Cemiplimab, or Cemiplimab + Fianlimab, … Recruiting

2022-501904-83-00 Phase I (FiH) 3 countries CEMIPLIMAB, FIANLIMAB; REGN5668; SARILUMAB; UBAMATAMAB
Dose Escalation Study with Bispecific Antibodies in Adult Patients with Lupus Nephritis Recruiting

2024-518288-37-00 Phase I (Other) 3 countries

Showing 1–24 of 74 trials

← All sponsors A–Z